This is a study to investigate the safety and efficacy of voriconazole for the treatment of
candidemia in critically ill non-neutropenic patients
- Patients with candidemia
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.